Erudio Healtherudio.com
Clinical trial · no report yet · Phase 2
NCT02677324
Study of ABT-199 (GDC-199) In Patients With Relapsed Or Refractory Waldenström Macroglobulinemia
- NCT02677324 ↗
- Completed
- Dana-Farber Cancer Institute
- Focused
We haven't built an HCP commentary report on NCT02677324 yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on NCT02677324 so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Channel | Indexed | |
|---|---|---|
| X threads | 3 |
The trial
ClinicalTrials.gov- Official title
- Phase II Study of ABT-199 (GDC-199) In Patients With Relapsed Or Refractory Waldenström Macroglobulinemia
- Phase
- Phase 2
- Status
- Completed
- Conditions
- Waldenstrom Macroglobulinemia
- Interventions
- ABT199
- Arms
- ABT199 · Experimental
- Enrollment
- 33
- Primary outcomes
- Overall Response Rate
- Sponsor
- Dana-Farber Cancer Institute with AbbVie
- Start
- May 9, 2016
- Primary completion
- Feb 14, 2020
- Results posted
- Yes
- Registry record
- NCT02677324 · updated May 11, 2022
Publications
linked from the registry- Castillo JJ, Guijosa A, Allan JN, Siddiqi T, Advani RH, Flynn CA, Meid K, Budano N, Nguyen J, Ramirez-Gamero A, Tsakmaklis N, Hunter ZR, Patterson CJ, Treon SP, Sarosiek S. Long-term follow-up of venetoclax monotherapy in previously treated patients with Waldenstrom macroglobulinemia. Blood Adv. 2025 Oct 14;9(19):4842-4847. doi: 10.1182/bloodadvances.2025016890. PubMed 40674749
- Castillo JJ, Allan JN, Siddiqi T, Advani RH, Meid K, Leventoff C, White TP, Flynn CA, Sarosiek S, Branagan AR, Demos MG, Guerrera ML, Kofides A, Liu X, Munshi M, Tsakmaklis N, Xu L, Yang G, Patterson CJ, Hunter ZR, Davids MS, Furman RR, Treon SP. Venetoclax in Previously Treated Waldenstrom Macroglobulinemia. J Clin Oncol. 2022 Jan 1;40(1):63-71. doi: 10.1200/JCO.21.01194. Epub 2021 Nov 18. PubMed 34793256